{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:01:25Z","timestamp":1790132485672,"version":"4.0.1"},"reference-count":20,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2008287"],"award-info":[{"award-number":["2008287"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The treat\u2010to\u2010target (T2T) strategy for the management of rheumatoid arthritis (RA) achieves remission or low disease activity in many patients. However, RA T2T is challenging in real\u2010world clinical environments. In this two\u2010stage audit, we evaluated the impact of transferring patients from a T2T intensive early arthritis clinic (EAC) to a general rheumatology (GR) clinic, then assessed outcomes of a clinical redesign to facilitate direct transfer from EAC to a dedicated RA clinic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively audited 216 patients attending an EAC in Brisbane, Australia, who were discharged to a GR clinic (cohort 1, 2004\u20132015) and 122 patients who were discharged directly to a dedicated, streamlined RA clinic (cohort 2, 2019\u20132023). EAC discharge occurred when patients reached low disease activity or remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median 28\u2010joint disease activity scores (DAS28) of 2.91, 95% confidence interval (2.38\u20133.26) (cohort 1) and 2.80 (2.37\u20133.28) (cohort 2) were achieved within 12 months in EAC. In cohort 1 patients returning to the GR clinic, median C\u2010reactive protein (CRP) and erythrocyte sedimentation rate (ESR) rose and disease\u2010modifying anti\u2010rheumatic drug (DMARD) doses decreased significantly. In contrast, cohort 2 transited without delay to the RA clinic, and there were no changes in CRP, ESR or DMARD doses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared to GR, establishing a streamlined RA clinic with a model of direct transfer of care reduced delayed follow\u2010up and improved medication adherence and maintenance of low disease activity after transition from EAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/imj.70649","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:23:42Z","timestamp":1790130222000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Direct transition to a streamlined rheumatoid arthritis clinic improves outcomes after discharge from an early arthritis clinic environment"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1336-2613","authenticated-orcid":false,"given":"Hyunjun Jonathan","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Rheumatology Princess Alexandra Hospital  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8751-8866","authenticated-orcid":false,"given":"Mitsi","family":"Blazos","sequence":"additional","affiliation":[{"name":"Frazer Institute The University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9264-6463","authenticated-orcid":false,"given":"Kevin Yen Chia","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Princess Alexandra Hospital  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-8386","authenticated-orcid":false,"given":"Ranjeny","family":"Thomas","sequence":"additional","affiliation":[{"name":"Frazer Institute The University of Queensland  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2361-3718","authenticated-orcid":false,"given":"Helen","family":"Benham","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Princess Alexandra Hospital  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick CG","year":"2008","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease\u2010modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen JS","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41584-019-0170-5","article-title":"Treat\u2010to\u2010target in rheumatoid arthritis \u2013 are we there yet?","volume":"15","author":"Vollenhoven R","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen JS","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/1756-185X.14051","article-title":"A patient\u2010centered knowledge translation tool for treat\u2010to\u2010target strategy in rheumatoid arthritis: patient and rheumatologist perspectives","volume":"24","author":"Benham H","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/imj.12896","article-title":"Safety and retention of combination triple disease\u2010modifying anti\u2010rheumatic drugs in new\u2010onset rheumatoid arthritis","volume":"45","author":"Cummins L","year":"2015","journal-title":"Intern Med J"},{"key":"e_1_2_8_8_1","first-page":"S7","article-title":"Treat\u2010to\u2010target: measures","volume":"30","author":"Yazici Y","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.semarthrit.2018.07.004","article-title":"Treat to target strategy in early rheumatoid arthritis versus routine care \u2013 a comparative clinical practice study","volume":"48","author":"Brinkmann GH","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/annrheumdis-2019-216819","article-title":"Is treat\u2010to\u2010target really working in rheumatoid arthritis? A longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)","volume":"79","author":"Ramiro S","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00296-019-04253-4","article-title":"Early arthritis clinic is effective for rheumatoid and psoriatic arthritides","volume":"39","author":"Nisar MK","year":"2019","journal-title":"Rheumatol Int"},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/acr.22540","article-title":"Continued participation in a ten\u2010year tight control treat\u2010to\u2010target study in rheumatoid arthritis: why keep patients doing their best?","volume":"67","author":"Markusse IM","year":"2015","journal-title":"Arthritis Care Res"},{"key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1756-185X.12126","article-title":"Patient age, ethnicity and waiting times determine the likelihood of non\u2010attendance at a first specialist rheumatology assessment","volume":"17","author":"Milne V","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.clinthera.2011.06.001","article-title":"Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review","volume":"33","author":"Blum MA","year":"2011","journal-title":"Clin Ther"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3899\/jrheum.151212","article-title":"Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review","volume":"43","author":"Curtis JR","year":"2016","journal-title":"J Rheumatol"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/PPA.S133222","article-title":"Shared decision\u2010making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs","volume":"11","author":"Lofland JH","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/00185787251337594","article-title":"Pharmacist's educational intervention on disease knowledge, medication adherence, and health\u2010related quality of life among rheumatoid arthritis patients: a single Centre, open\u2010label, randomised controlled study","volume":"60","author":"Khadka S","year":"2025","journal-title":"Hosp Pharm"},{"key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/PPA.S140457","article-title":"Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta\u2010analysis","volume":"11","author":"Li L","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_8_19_1","first-page":"814","article-title":"Erythrocyte sedimentation rate and C\u2010reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients","volume":"26","author":"Keenan RT","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3899\/jrheum.080770","article-title":"Erythrocyte sedimentation rate, C\u2010reactive protein, or rheumatoid factor are normal at presentation in 35%\u201345% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States","volume":"36","author":"Sokka T","year":"2009","journal-title":"J Rheumatol"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","article-title":"Validation of the 28\u2010joint Disease Activity Score (DAS28) and European league against rheumatism response criteria based on C\u2010reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate","volume":"68","author":"Wells G","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70649","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.70649","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:23:46Z","timestamp":1790130226000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.70649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":20,"alternative-id":["10.1111\/imj.70649"],"URL":"https:\/\/doi.org\/10.1111\/imj.70649","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"2026-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"imj.70649"}}